The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Home Explore BioSpectrum Aisa March 2023
View in Fullscreen

HOW PLAUSIBLE IS ENDINGHOW PLAUSIBLE IS ENDING TB SCOURGE?
Tuberculosis (TB) has been the leading cause of death from a single infectious agent, ranking above HIV/AIDS for a long time. And, presently, Asia Pacific is right in the thick of it. South-eastern Asia (SEA) is home to 26 per cent of the world’s population with a 43 per cent burden of TB incidence, according to the World Health Organisation’s (WHO) global TB report 2021. Over the last three years, countries around the world, including in Asia and the Pacific,
have faced double pandemics –COVID-19 and TB. Unfortunately, during this time, progress toward TB elimination stalled and, in some cases, reversed. COVID-19 made it harder for people to access TB diagnostics and care, eading to increases in cases and deaths since
2019. Four countries, India, Indonesia, the Philippines, and Myanmar accounted for most of the estimated increase in TB deaths, globally, in 2021. Not all is lost though. The countries in
the region, especially India and Indonesia, have renewed their efforts to eliminate TB. India launched the TB Free India campaign – a plan to eliminate tuberculosis by 2025, five years ahead of the target set by the UN’s sustainable development goals. Indonesia received a $300 million loan from the World Bank to improve overage, quality and efficiency of TB
response in the country. When observing World TB day this year on March 24, let’s take stock of the progress made by Asian countries in eliminating this dreaded disease and the way forward.

Like this book? You can publish your book online for free in a few minutes!
Share

Related Publications

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by MMA Media, 2023-03-05 02:16:49

BioSpectrum Aisa March 2023

HOW PLAUSIBLE IS ENDINGHOW PLAUSIBLE IS ENDING TB SCOURGE?
Tuberculosis (TB) has been the leading cause of death from a single infectious agent, ranking above HIV/AIDS for a long time. And, presently, Asia Pacific is right in the thick of it. South-eastern Asia (SEA) is home to 26 per cent of the world’s population with a 43 per cent burden of TB incidence, according to the World Health Organisation’s (WHO) global TB report 2021. Over the last three years, countries around the world, including in Asia and the Pacific,
have faced double pandemics –COVID-19 and TB. Unfortunately, during this time, progress toward TB elimination stalled and, in some cases, reversed. COVID-19 made it harder for people to access TB diagnostics and care, eading to increases in cases and deaths since
2019. Four countries, India, Indonesia, the Philippines, and Myanmar accounted for most of the estimated increase in TB deaths, globally, in 2021. Not all is lost though. The countries in
the region, especially India and Indonesia, have renewed their efforts to eliminate TB. India launched the TB Free India campaign – a plan to eliminate tuberculosis by 2025, five years ahead of the target set by the UN’s sustainable development goals. Indonesia received a $300 million loan from the World Bank to improve overage, quality and efficiency of TB
response in the country. When observing World TB day this year on March 24, let’s take stock of the progress made by Asian countries in eliminating this dreaded disease and the way forward.

Keywords: Tuberculosis,HealthScience

For queries, please contact : [email protected] TO SUBSCRIBE SCAN THE QR CODE FROM YOUR MOBILE www.mmactiv.com An publication Comprehensive Ecosystem Coverage Spiraling Growth TRUSTED B2B MEDIA IN BIOTECH, HEALTHCARE & AGRO SECTOR Policy Business Science Technology The only B2B Media for the complete ecosystem of: Nutraceuticals, Dietary Supplements, Functional Foods, Ingredients, Food Processing www.nuffoodsspectrum.in www.biospectrumasia.com Trusted across APAC by Biotech & Healthcare sectors for over a decade BioSpectrum India NuFFooDs Spectrum BioSpectrum Asia AgroSpectrum India Trusted by Biotech & Healthcare sectors in India for over a decade www.biospectrumindia.com Trusted by Agro Sector in India www.agrospectrumindia.com


Designed for stem cell process development and aggregate cell cultures: BioBLU 0.3sc with 8-blade impeller With working volumes of 60 – 250 mL the DASbox is the optimal tool for advanced cell culture and microbial process development and Design of Experiments (DoE) applications. All critical parameters can be precisely controlled. > Parallel set-up of up to 24 bioreactors > Perfectly suited for microbial and cell culture applications > Liquid-free exhaust condensation > Fully mass fl ow-controlled gas mixing > Available with single-use vessels Most Compact QbD-driven process development with the DASbox® Mini Bioreactor System www.eppendorf.com/DASbox Eppendorf® and the Eppendorf Brand Design are registered trademarks of Eppendorf SE, Germany. DASbox® is a registered trademark of DASGIP Information and Process Technology GmbH, Juelich, Germany. All rights reserved, including graphics and images. Copyright ©2023 by Eppendorf SE.


Click to View FlipBook Version